glp 1 agonist GLP-1 receptor agonists show promise in treating substance use disorders Glucagon-like peptide-1 receptor: mechanisms and

Taheri H, Malek M, Ismail-Beigi F et al (2020) Effect of Empagliflozin on Liver Steatosis and Fibrosis in Patients With Non-Alcoholic Fatty Liver Disease Without Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial

Possible Side Effects and Precautions Common side effects include: Nausea or vomiting (especially in early weeks) Bloating or mild stomach discomfort Fatigue Rare: pancreatitis or gallbladder issues Important: Never start GLP-1 therapy without consulting a doctor

Preoperative Assessment Preoperative medication reconciliation should explicitly include incretin therapy

As more people turn to these weight loss medications for help, adopting a holistic approach to preserving muscle and skin health is crucial

Cardiovasc Res (2020) 116(5):91630